All programs in this SPORE use human specimens for translational research directed at reducing the incidence of and mortality from colorectal and pancreatic cancer. The Human Tissue Resource and Logistics Core was built upon the highly successful existing bank established in 1986 for the Bowel Tumor Working Group. At the end of 1995, the Resource included 910 colorectal cancer resections, 169 colorectal adenoma resections, 52 colorectal polypectomy specimens, 62 hepatic resections for metastatic colorectal cancer, 20l pancreatic cancer resections, 112 xenografts of colorectal carcinoma, 97 xenografts o pancreatic carcinoma, 127 fecal specimens, and 2574 blood specimens. The mechanisms for collecting specimens required for the research activities of the SPORE remain in place in the various patient contact locations. This Core facility banks a wide range of tissues from resection specimens for colorectal and pancreatic cancers. The Resource provides for procurement of fecal and blood specimens, including peripheral blood leukocytes, plasma and serum, as well as ERCP fluids, nasogastric and duodenal capsule fluid, and peritoneal washings. The Core supports xenografts of colorectal and pancreatic cancers in nude mice. In addition, the distribution and retrieval of a standardized food frequency questionnaire for dietary history and family history is carried out through the Core for patients with specimens in the Resource. The Core includes a mechanism for database management and specimen distribution, including procedures for prioritization of requested materials within and external to the Johns Hopkins GI Cancer SPORE. The existing procedures provide quality control of specimens for research without compromise of the diagnostic, clinically important pathological evaluation of the specimens via the participation of pathologists with expertise in colorectal and pancreatic cancer. Members of the clinical departments with primary patient contact are participants in the individual research projects and thus also contribute to the Core for maximal and effective accumulation of satisfactory specimens.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA062924-06
Application #
6102969
Study Section
Project Start
1999-01-01
Project End
1999-12-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
6
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Kuboki, Yuko; Fischer, Catherine G; Beleva Guthrie, Violeta et al. (2018) Single-cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions. J Pathol :
Zhang, Jiajia; Quadri, Shafat; Wolfgang, Christopher L et al. (2018) New Development of Biomarkers for Gastrointestinal Cancers: From Neoplastic Cells to Tumor Microenvironment. Biomedicines 6:
Hata, Tatsuo; Suenaga, Masaya; Marchionni, Luigi et al. (2018) Genome-Wide Somatic Copy Number Alterations and Mutations in High-Grade Pancreatic Intraepithelial Neoplasia. Am J Pathol 188:1723-1733
Noë, Michaël; Rezaee, Neda; Asrani, Kaushal et al. (2018) Immunolabeling of Cleared Human Pancreata Provides Insights into Three-Dimensional Pancreatic Anatomy and Pathology. Am J Pathol 188:1530-1535
Schunke, Kathryn J; Rosati, Lauren M; Zahurak, Marianna et al. (2018) Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancers. Adv Radiat Oncol 3:42-51
Zhang, Jiajia; Wolfgang, Christopher L; Zheng, Lei (2018) Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer. Cancers (Basel) 10:
Dejea, Christine M; Fathi, Payam; Craig, John M et al. (2018) Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science 359:592-597
Staedtke, Verena; Bai, Ren-Yuan; Kim, Kibem et al. (2018) Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome. Nature 564:273-277
Deng, Yang; Tu, Huakang; Pierzynski, Jeanne A et al. (2018) Determinants and prognostic value of quality of life in patients with pancreatic ductal adenocarcinoma. Eur J Cancer 92:20-32
Tamura, Koji; Yu, Jun; Hata, Tatsuo et al. (2018) Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. Proc Natl Acad Sci U S A 115:4767-4772

Showing the most recent 10 out of 883 publications